Table 2.
Characteristics of maternal and neonatal outcomes
| Variable | No bladder involvement (N = 36) |
bladder Involvement (N = 17) |
Pvalue |
|---|---|---|---|
| Blood transfusion | 25(69.44%) | 14(82.35%) | 0.508 |
|
Estimated blood loss (mL) M(P25,P75) 95% CI |
1850.00(1000.00, 2500.00) (1514.49-2413.28) |
1500.00(750.00, 2250.00) 1138.88–2367.00 |
0.559 |
|
Number of days in hospital postoperative(d) M(P25,P75) 95% CI |
9.0(6.00, 11.75) 8.35–12.43 |
11.0(8.00, 19.00) 10.16–17.49 |
0.039 |
| fetal weight(g) | 2672.1 ± 440.8 | 2720.6 ± 872.3 | 0.789 |
| ICU | 11(30.56%) | 11(64.70%) | 0.019 |
| 5-min APGAR score < 7 | 1(2.78%) | 2(11.76%) | 0.238 |
| Hysterectomy | 8(22.22%) | 11(64.71%) | 0.003 |
| Cystoscopy or Ureteroscopy | 3(8.33%) | 16(94.12%) | 0.000 |
| Uterine artery embolization | 4(11.11%) | 8(47.06%) | 0.001 |
| Embolization of the internal iliac arteries | 2(5.56%) | 5(29.41%) | 0.004 |
ICU:intensive care unit